Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters

INTRODUCTION: Immunocompromised patients have been shown to have an impaired immune response to COVID-19 vaccines. METHODS: Here we compared the B-cell, T-cell and neutralizing antibody response to WT and Omicron BA.2 SARS-CoV-2 virus after the fourth dose of mRNA COVID-19 vaccines in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Rescigno, Maria, Agrati, Chiara, Salvarani, Carlo, Giannarelli, Diana, Costantini, Massimo, Mantovani, Alberto, Massafra, Raffaella, Zinzani, Pier Luigi, Morrone, Aldo, Notari, Stefania, Matusali, Giulia, Pinter, Giuseppe Lauria, Uccelli, Antonio, Ciliberto, Gennaro, Baldanti, Fausto, Locatelli, Franco, Silvestris, Nicola, Sinno, Valentina, Turola, Elena, Lupo-Stanghellini, Maria Teresa, Apolone, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911671/
https://www.ncbi.nlm.nih.gov/pubmed/36776853
http://dx.doi.org/10.3389/fimmu.2023.1104124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911671/
https://www.ncbi.nlm.nih.gov/pubmed/36776853
http://dx.doi.org/10.3389/fimmu.2023.1104124

Ejemplares similares